Pleural extramedullary hematopoiesis;La plèvre myéloïde

Revue de Medecine Interne

Volumn 29, Issue 7, 2008, Pages 573-576

  Mrabti, H ^a   Chelghoum, M ^a   Odier, L ^a   Chassagne Clement C ^a   Pavic, M ^b   Devaux, Y ^a  

^a CENTRE LÉON BÉRARD   (France)

^b Hôpital I A Desgenettes   (France)

Author keywords

Agnogenic myeloid metaplasia; Extramedullary hematopoiesis; Pleural effusion

Indexed keywords

HYDROXYUREA;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE CONTROL; DISEASE SEVERITY; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; HUMAN; LABORATORY TEST; MYELOID METAPLASIA; PLEURA DISEASE; PROGNOSIS;

FEMALE; HEMATOPOIESIS; HUMANS; HYDROXYUREA; MIDDLE AGED; PLEURAL EFFUSION;

EID: 45849099489     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.12.002     Document Type: Article

References (22)

1. Dupriez B., and Demory J.L. Myelofibrosis with myeloid metaplasia: diagnosis and treatment. Rev Prat 55 (2005) 1680-1685
2. Hassan F., Nadrous H.F., Krowka M.J., McClure R.F., Tefferi A., and Lim K.G. Agnogenic myeloid metaplasia with pleural extramedullary leukemic transformation. Leuk Lymphoma 45 (2004) 815-818
3. Barlett R.P., Greip P.R., Tefferi A., Cups R.O., Mullan B.P., and Trastek V.S. Extramedullary hematopoiesis manifesting as a symptomatic pleural effusion. Mayo Clin Proc 70 (1995) 1161-1164
4. Oren I., Goldman A., Haddad N., Azzam Z., Krivoy N., and Alroy G. Ascites ans pleural effusions secondary to extramedullary hematopoiesis. Case report. Am J Med Sci 318 (1999) 286
5. Aessopos A., Tassiopoulos S., Farmakis D., Moyssakis I., Kati M., Polonifi K., et al. Extramedullary hematopoiesis-related pleural effusion: the case of beta-thalassemia. Ann Thorac Surg 81 (2006) 2037-2043
6. Dupriez B., and Demory J.L. La splénomégalie myéloide : mise à jours des citères diagnostiques, des facteurs pronostiques et du traitement. Hematologie 8 (2002) 197
7. Tefferi A., Lasho T., Schwager S., Steensma D., Mesa R., Li C.Y., et al. The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates. Br J Haematol 13 (2005) 320-328
8. Baxter E.J., Scott L.M., Campbell P.J., East C., Fourouclas N., Swanton S., et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365 (2005) 1054-1061
9. Kralovics R., Passamonti F., Buser A.S., Soon-Siong T., Tiedt R., Passweg J.R., et al. A gain of function mutation in Jak2 is frequently found in patients with myeloproliferative disorders. N Engl J Med 352 (2005) 1779-1790
10. Campbell P., Baxter J., Beer P., Scott L., Bench A., Huntly B., et al. Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation. Blood 108 (2006) 3548-3555
11. Campbell P.J., Scott L.M., Buck G., Wheatley K., East C.L., Marsden J.T., et al. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet 366 (2005) 1945-1953
12. Pardanani A., Levine R., Lasho T., Pikman Y., Mesa R.A., Wadleigh M., et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 108 (2006) 3472-3476
13. Lasho T.L., Pardanani A., McClure R.F., Mesa R.A., Levine R.L., Gilliland D.G., et al. Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time. Br J Haematol 135 (2006) 683-687
14. Roger D., Yusen, Martin H., and Kollef M.H. Acute respiratory failure due to extramedullary hematopoiesis. Chest 108 (1995) 1170-1172
15. Pitock J.A., Reinhard E.H., Justus U.W., and Mendelson R.S. A clinical and pathological study of seventy cases of myelofibrosis. Ann Intern Med 57 (1962) 73-84
16. Koch C.A., Li C.Y., Mesa R.A., and Tefferi A. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment. Mayo Clin Proc 78 (2003) 1223-1233
17. Asakura S., and Colby T. Agnogenic myeloid metaplasia with extramedullary hematopoiesis and fibrosis in the lung. Chest 105 (1994) 1866-1868
18. Ziakas P.D., Voulgarelis M., Felekouras E., Anagnostou D., and Tzelepis G.E. Myelofibrosis-associated massive splenomegaly: a cause of increased intra-abdominal pressure, pulmonary hypertension, and positional dyspnea. Am J Hematol (2005) 80128-80132
19. Rumi E., Passamonti F., Boveri E., De Amici M., Astori C., Braschi M., et al. Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia. Am J Hematol 81 (2006) 124-127
20. Merup M., Lazarevic V., Nahi H., Andreasson B., Malm C., Nilsson L., et al. Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens. Br J Haematol 135 (2006) 367-373
21. Dingli D., Schwager S., Mesa R., Li C.Y., and Tefferi A. Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system. Cancer 106 (2006) 623-630
22. Jowitt S.N., Burke D.K., Leggat H.M., Lewis P.S., and Cryer R.J. Pleural effusion secondary to extramedullary haemopoiesis in a patient with idiopathic myelofibrosis responding to pleurodesis and hydroxyurea. Clin Lab Haematol 19 (1997) 283-285